169 related articles for article (PubMed ID: 38612755)
21. Systematic pan-cancer analyses of the potential function of the Golgi scaffold protein PAQR3.
Ling ZN; Hong LL; Wu J; Ling ZQ
Sci Rep; 2024 Feb; 14(1):3030. PubMed ID: 38321173
[TBL] [Abstract][Full Text] [Related]
22. Glypican 3 and glypican 4 are juxtaposed in Xq26.1.
Huber R; Mazzarella R; Chen CN; Chen E; Ireland M; Lindsay S; Pilia G; Crisponi L
Gene; 1998 Dec; 225(1-2):9-16. PubMed ID: 9931407
[TBL] [Abstract][Full Text] [Related]
23. The Shear Stress-Regulated Expression of Glypican-4 in Endothelial Dysfunction In Vitro and Its Clinical Significance in Atherosclerosis.
Urschel K; Hug KP; Zuo H; Büttner M; Furtmair R; Kuehn C; Stumpfe FM; Botos B; Achenbach S; Yuan Y; Dietel B; Tauchi M
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511353
[TBL] [Abstract][Full Text] [Related]
24. GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt/β-catenin signaling in lung adenocarcinoma.
Yuan S; Yu Z; Liu Q; Zhang M; Xiang Y; Wu N; Wu L; Hu Z; Xu B; Cai T; Ma X; Zhang Y; Liao C; Wang L; Yang P; Bai L; Li Y
Oncogene; 2016 Nov; 35(47):6120-6131. PubMed ID: 27157618
[TBL] [Abstract][Full Text] [Related]
25. The Glypican-4 Gene Polymorphism rs1048369 and Susceptibility to Epstein-Barr Virus-Positive and -Negative Nasopharyngeal Carcinoma in Northern China.
Liu S; Liu W; Zhao D; Zhang Y; Zhao Z; Luo B
Oncol Res Treat; 2019; 42(11):572-579. PubMed ID: 31522169
[TBL] [Abstract][Full Text] [Related]
26. LSR Promotes Cell Proliferation and Invasion in Lung Cancer.
Zhang M; Ma C
Comput Math Methods Med; 2021; 2021():6651907. PubMed ID: 33763152
[TBL] [Abstract][Full Text] [Related]
27. p53 suppression is essential for oncogenic SPAG5 upregulation in lung adenocarcinoma.
Wang T; Li K; Song H; Xu D; Liao Y; Jing B; Guo W; Hu M; Kuang Y; Sun B; Ling J; Zhang T; Xu J; Yao F; Deng J
Biochem Biophys Res Commun; 2019 May; 513(2):319-325. PubMed ID: 30955859
[TBL] [Abstract][Full Text] [Related]
28. High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation through Regulation of the Cell Cycle.
Tang X; Zhou H; Liu Y
Dis Markers; 2023; 2023():9292536. PubMed ID: 36712920
[TBL] [Abstract][Full Text] [Related]
29. Localization of glypican-4 in different membrane microdomains is involved in the regulation of Wnt signaling.
Sakane H; Yamamoto H; Matsumoto S; Sato A; Kikuchi A
J Cell Sci; 2012 Jan; 125(Pt 2):449-60. PubMed ID: 22302992
[TBL] [Abstract][Full Text] [Related]
30. Differential expression and functions of Ehm2 transcript variants in lung adenocarcinoma.
Li S; Ma J; Si Y; Cheng S; Hu M; Zhi X; Li B; Yu H; Jiang WG
Int J Oncol; 2019 May; 54(5):1747-1758. PubMed ID: 30816447
[TBL] [Abstract][Full Text] [Related]
31. Identification and Validation of a Proliferation-Associated Score Model Predicting Survival in Lung Adenocarcinomas.
Bian Y; Sui Q; Bi G; Zheng Y; Zhao M; Yao G; Xue L; Zhang Y; Fan H
Dis Markers; 2021; 2021():3219594. PubMed ID: 34721732
[TBL] [Abstract][Full Text] [Related]
32. FAM83H-AS1 is a noncoding oncogenic driver and therapeutic target of lung adenocarcinoma.
Wang S; Han C; Liu T; Ma Z; Qiu M; Wang J; You Q; Zheng X; Xu W; Xia W; Xu Y; Hu J; Xu L; Yin R
Clin Transl Med; 2021 Feb; 11(2):e316. PubMed ID: 33634993
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
[TBL] [Abstract][Full Text] [Related]
34. Serum glypican-4 is associated with the 10-year clinical outcome of patients with peripheral artery disease.
Muendlein A; Heinzle C; Leiherer A; Geiger K; Brandtner EM; Gaenger S; Fraunberger P; Saely CH; Drexel H
Int J Cardiol; 2022 Dec; 369():54-59. PubMed ID: 35944770
[TBL] [Abstract][Full Text] [Related]
35. Serum glypican 4 level in obese children and its relation to degree of obesity.
Leelalertlauw C; Korwutthikulrangsri M; Mahachoklertwattana P; Chanprasertyothin S; Khlairit P; Pongratanakul S; Poomthavorn P
Clin Endocrinol (Oxf); 2017 Dec; 87(6):689-695. PubMed ID: 28746787
[TBL] [Abstract][Full Text] [Related]
36. Serum glypican-4 is a marker of future vascular risk and mortality in coronary angiography patients.
Muendlein A; Brandtner EM; Leiherer A; Geiger K; Heinzle C; Gaenger S; Fraunberger P; Mader A; Saely CH; Drexel H
Atherosclerosis; 2022 Mar; 345():33-38. PubMed ID: 35202959
[TBL] [Abstract][Full Text] [Related]
37. Neuronal Glypican4 promotes mossy fiber sprouting through the mTOR pathway after pilocarpine-induced status epilepticus in mice.
Ma KG; Hu HB; Zhou JS; Ji C; Yan QS; Peng SM; Ren LD; Yang BN; Xiao XL; Ma YB; Wu F; Si KW; Wu XL; Liu JX
Exp Neurol; 2022 Jan; 347():113918. PubMed ID: 34748756
[TBL] [Abstract][Full Text] [Related]
38. A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks.
Yuan C; Chen H; Tu S; Huang HY; Pan Y; Gui X; Kuang M; Shen X; Zheng Q; Zhang Y; Cheng C; Hong H; Tao X; Peng Y; Yao X; Meng F; Ji H; Shao Z; Sun Y
Genome Biol; 2021 May; 22(1):156. PubMed ID: 34001209
[TBL] [Abstract][Full Text] [Related]
39. Heparan Sulfated Glypican-4 Is Released from Astrocytes by Proteolytic Shedding and GPI-Anchor Cleavage Mechanisms.
Huang K; Park S
eNeuro; 2021; 8(4):. PubMed ID: 34301723
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
